Europe Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2029
The Europe syndromic multiplex diagnostic market is projected to register a CAGR of 8.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029
Market Segmentation
Europe Syndromic Multiplex Diagnostic Market, By Product and Services (Reagents & Consumables, Instruments, Software & Accessories and Services), Infection type (Viral, Bacterial, Parasites and Fungal), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Sepsis, Meningitis and Others), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis panel and Others), End User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes and Others), Country (Germany, France ,U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium Rest of Europe) – Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of Europe syndromic multiplex diagnostic market are:
• Increase in prevalence of infectious diseases
• Increasing demand of fast and accurate diagnostic results
Market Players
The major companies which are dealing in the Europe syndromic multiplex diagnostic are listed below:
• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH)
• Prominex Inc.
• Curetis (A Subsidiary of OpGen, Inc.)
Company Profiles
• BioFire Diagnostics (A Subsidiary of bioMérieux SA)
• Seegene Inc.
• Luminex Corporation. A DiaSorin Company
• F. Hoffmann-La Roche Ltd
• BD
• Bio-Rad Laboratories, Inc.
• Cepheid (A Subsidiary of Danaher)
• QIAGEN
• Abbott
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Biocartis
• QuantuMDx Group Ltd.
• Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH)
• Prominex Inc.
• Curetis (A Subsidiary of OpGen, Inc.)
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Europe Syndromic Multiplex Diagnostic Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product And Services Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter's Five Forces
- 4.3 Market Share Per Panel, For Top 3 Players (2021)
- 5 Europe Syndromic Multiplex Diagnostic Market: Regulations
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Infectious Diseases
- 6.1.2 Rising Adoption Of Molecular Diagnostics Techniques
- 6.1.3 Increasing Regulatory Approval For Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Testing
- 6.1.4 Increasing Demand For Fast And Accurate Diagnostic Results
- 6.2 Restraints
- 6.2.1 High Cost Of Diagnostic Products
- 6.2.2 Explicit Limitation Of Syndromic Multiplex Diagnostic
- 6.3 Opportunities
- 6.3.1 Strategic Initiatives Taken By Market Players
- 6.3.2 Rising Diagnostic Healthcare Expenditure
- 6.3.3 Introduction Of Technological Advanced Products
- 6.4 Challenges
- 6.4.1 Product Recalls
- 6.4.2 Lack Of Skilled Professionals And Barriers Faced In Conducting Diagnostic Tests
- 7 Europe Syndromic Multiplex Diagnostic Market, By Product & Services
- 7.1 Overview
- 7.2 Reagents & Consumables
- 7.3 Instruments, Software & Accessories
- 7.4 Services
- 8 Europe Syndromic Multiplex Diagnostic Market, By Infection Type
- 8.1 Overview
- 8.2 Viral
- 8.2.1 Coronavirus
- 8.2.2 Influenza Virus
- 8.2.3 Adenovirus
- 8.2.4 Rhinovirus
- 8.2.5 Rotavirus
- 8.2.6 Others
- 8.3 Bacterial
- 8.3.1 Pneumoniae
- 8.3.2 Bordetella Pertussis
- 8.3.3 Staphylococcus
- 8.3.4 Others
- 8.4 Parasites
- 8.5 Fungal
- 9 Europe Syndromic Multiplex Diagnostic Market, By Disease
- 9.1 Overview
- 9.2 Respiratory Infections
- 9.3 Gastroenteritis
- 9.4 Sexually Transmitted Infections
- 9.5 Sepsis
- 9.6 Meningitis
- 9.7 Others
- 10 Europe Syndromic Multiplex Diagnostic Market, By Panels Type
- 10.1 Overview
- 10.2 Respiratory Panel
- 10.3 Gi-enteric Panel
- 10.4 Sexually Transmitted Disease Panel
- 10.5 Blood-sepsis Panel
- 10.6 Meningitis Panel
- 10.7 Others
- 11 Europe Syndromic Multiplex Diagnostic Market, By End User
- 11.1 Overview
- 11.2 Hospitals
- 11.3 Clinical Laboratories
- 11.4 Pharmaceutical & Biotechnology Companies
- 11.5 Research Institutes
- 11.6 Others
- 12 Europe Syndromic Multiplex Diagnostic Market, By Region
- 12.1 Europe
- 12.1.1 Germany
- 12.1.2 U.K.
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Netherlands
- 12.1.7 Switzerland
- 12.1.8 Russia
- 12.1.9 Belgium
- 12.1.10 Turkey
- 12.1.11 Rest Of Europe
- 13 Europe Syndromic Multiplex Diagnostic Market: Company Landscape
- 13.1 Company Share Analysis: Europe
- 14 Swot Analysis
- 15 Company Profile
- 15.1 Biofire Diagnostics (A Subsidiary Of Biomérieux Sa)
- 15.1.1 Company Snapshot
- 15.1.2 Revenue Analysis
- 15.1.3 Company Share Analysis
- 15.1.4 Product Portfolio
- 15.1.5 Recent Developments
- 15.2 F. Hoffmann-la Roche Ltd
- 15.2.1 Company Snapshot
- 15.2.2 Revenue Analysis
- 15.2.3 Company Share Analysis
- 15.2.4 Product Portfolio
- 15.2.5 Recent Development
- 15.3 Luminex Corporation. A Diasorin Company
- 15.3.1 Company Snapshot
- 15.3.2 Recent Financials
- 15.3.3 Company Share Analysis
- 15.3.4 Product Portfolio
- 15.3.5 Recent Development
- 15.4 Cepheid (A Subsidiary Of Danaher)
- 15.4.1 Company Snapshot
- 15.4.2 Recent Financials
- 15.4.3 Company Share Analysis
- 15.4.4 Product Portfolio
- 15.4.5 Recent Developments
- 15.5 Qiagen
- 15.5.1 Company Snapshot
- 15.5.2 Recent Financials
- 15.5.3 Company Share Analysis
- 15.5.4 Product Portfolio
- 15.5.5 Recent Development
- 15.6 Abbott
- 15.6.1 Company Snapshot
- 15.6.2 Revenue Analysis
- 15.6.3 Product Portfolio
- 15.6.4 Recent Development
- 15.7 Akonni Biosystems, Inc.
- 15.7.1 Company Snapshot
- 15.7.2 Product Portfolio
- 15.7.3 Recent Development
- 15.8 Applied Biocode, Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Product Portfolio
- 15.8.3 Recent Developments
- 15.9 Bd
- 15.9.1 Company Snapshot
- 15.9.2 Revenue Analysis
- 15.9.3 Product Portfolio
- 15.9.4 Recent Developments
- 15.10 Biocartis
- 15.10.1 Company Snapshot
- 15.10.2 Revenue Analysis
- 15.10.3 Product Portfolio
- 15.10.4 Recent Development
- 15.11 Bio-rad Laboratories, Inc.
- 15.11.1 Company Snapshot
- 15.11.2 Revenue Analysis
- 15.11.3 Product Portfolio
- 15.11.4 Recent Development
- 15.12 Bosch Healthcare Solutions Gmbh (A Subsidiary Of Robert Bosch Gmbh)
- 15.12.1 Company Snapshot
- 15.12.2 Revenue Analysis
- 15.12.3 Product Portfolio
- 15.12.4 Recent Development
- 15.13 Curetis (A Subsidiary Of Opgen, Inc.)
- 15.13.1 Company Snapshot
- 15.13.2 Recent Financials
- 15.13.3 Product Portfolio
- 15.13.4 Recent Developments
- 15.14 Hologic, Inc.
- 15.14.1 Company Snapshot
- 15.14.2 Recent Financials
- 15.14.3 Product Portfolio
- 15.14.4 Recent Development
- 15.15 Mirxes Pte Ltd.
- 15.15.1 Company Snapshot
- 15.15.2 Product Portfolio
- 15.15.3 Recent Development
- 15.16 Nanōmix, Inc.
- 15.16.1 Company Snapshot
- 15.16.2 Product Portfolio
- 15.16.3 Recent Development
- 15.17 Prominex Inc.
- 15.17.1 Company Snapshot
- 15.17.2 Product Portfolio
- 15.17.3 Recent Development
- 15.18 Quantumdx Group Ltd.
- 15.18.1 Company Snapshot
- 15.18.2 Product Portfolio
- 15.18.3 Recent Developments
- 15.19 Seegene Inc.
- 15.19.1 Company Snapshot
- 15.19.2 Revenue Analysis
- 15.19.3 Product Portfolio
- 15.19.4 Recent Developments
- 15.20 Siemens Healthcare Gmbh
- 15.20.1 Company Snapshot
- 15.20.2 Recent Financials
- 15.20.3 Product Portfolio
- 15.20.4 Recent Development
- 15.21 Thermofisher Scientific Inc.
- 15.21.1 Company Snapshot
- 15.21.2 Recent Financials
- 15.21.3 Product Portfolio
- 15.21.4 Recent Development
- 16 Questionnaire
- 17 Related Reports
- List Of Tables
- Table 1 Cost Of The Product
- Table 2 Europe Syndromic Multiplex Diagnostic Market, By Product & Services, 2020-2029 (Usd Million)
- Table 3 Europe Reagents & Consumables In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 4 Europe Instruments, Software & Accessories In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 5 Europe Services In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 6 Europe Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 7 Europe Viral In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 8 Europe Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 9 Europe Bacterial In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 10 Europe Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 11 Europe Parasites In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 12 Europe Fungal In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 13 Europe Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 14 Europe Respiratory Infections In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 15 Europe Gastroenteritis In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 16 Europe Sexually Transmitted Infections In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 17 Europe Sepsis In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 18 Europe Meningitis In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 19 Europe Others In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 20 Europe Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 21 Europe Respiratory Panel In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 22 Europe Gi-enteric Panel In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 23 Europe Sexually Transmitted Disease Panel In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 24 Europe Blood-sepsis Panel In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 25 Europe Meningitis Panel In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 26 Europe Others In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 27 Europe Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 28 Europe Hospitals In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 29 Europe Clinical Laboratories In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 30 Europe Pharmaceutical & Biotechnology Companies In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 31 Europe Research Institutes In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 32 Europe Others In Syndromic Multiplex Diagnostic Market, By Region, 2020-2029 (Usd Million)
- Table 33 Europe Syndromic Multiplex Diagnostic Market, By Country, 2020-2029 (Usd Million)
- Table 34 Europe Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 35 Europe Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 36 Europe Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 37 Europe Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 38 Europe Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 39 Urope Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 40 Europe Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 41 Germany Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 42 Germany Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 43 Germany Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 44 Germany Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 45 Germany Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 46 Germany Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 47 Germany Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 48 U.K. Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 49 U.K. Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 50 U.K. Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 51 U.K. Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 52 U.K. Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 53 U.K. Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 54 U.K. Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 55 France Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 56 France Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 57 France Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 58 France Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 59 France Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 60 France Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 61 France Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 62 Italy Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 63 Italy Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 64 Italy Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 65 Italy Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 66 Italy Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 67 Italy Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 68 Italy Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 69 Spain Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 70 Spain Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 71 Spain Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 72 Spain Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 73 Spain Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 74 Spain Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 75 Spain Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 76 Netherlands Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 77 Netherlands Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 78 Netherlands Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 79 Netherlands Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 80 Netherlands Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 81 Netherlands Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 82 Netherlands Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 83 Switzerland Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 84 Switzerland Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 85 Switzerland Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 86 Switzerland Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 87 Switzerland Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 88 Switzerland Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 89 Switzerland Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 90 Russia Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 91 Russia Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 92 Russia Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 93 Russia Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 94 Russia Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 95 Russia Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 96 Russia Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 97 Belgium Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 98 Belgium Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 99 Belgium Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 100 Belgium Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 101 Belgium Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 102 Belgium Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 103 Belgium Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 104 Turkey Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- Table 105 Turkey Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 106 Turkey Viral In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 107 Turkey Bacterial In Syndromic Multiplex Diagnostic Market, By Infection Type, 2020-2029 (Usd Million)
- Table 108 Turkey Syndromic Multiplex Diagnostic Market, By Disease, 2020-2029 (Usd Million)
- Table 109 Turkey Syndromic Multiplex Diagnostic Market, By Panels Type, 2020-2029 (Usd Million)
- Table 110 Turkey Syndromic Multiplex Diagnostic Market, By End User, 2020-2029 (Usd Million)
- Table 111 Rest Of Europe Syndromic Multiplex Diagnostic Market, By Product And Services, 2020-2029 (Usd Million)
- List Of Figures
- Figure 1 Europe Syndromic Multiplex Diagnostic Market: Segmentation
- Figure 2 Europe Syndromic Multiplex Diagnostic Market: Data Triangulation
- Figure 3 Europe Syndromic Multiplex Diagnostic Market: Droc Analysis
- Figure 4 Europe Syndromic Multiplex Diagnostic Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Syndromic Multiplex Diagnostic Market: Company Research Analysis
- Figure 6 Europe Syndromic Multiplex Diagnostic Market: Interview Demographics
- Figure 7 Europe Syndromic Multiplex Diagnostic Market: Dbmr Market Position Grid
- Figure 8 Europe Syndromic Multiplex Diagnostic Market: End User Coverage Grid
- Figure 9 Europe Syndromic Multiplex Diagnostic Market: Vendor Share Analysis
- Figure 10 Europe Syndromic Multiplex Diagnostic Market: Segmentation
- Figure 11 Increasing Prevalence And Incidence Of Infectious Diseases Is Expected To Drive The Europe Syndromic Multiplex Diagnostic Market In The Forecast Period
- Figure 12 Reagents & Consumables Segment Is Expected To Account For The Largest Share Of The Europe Syndromic Multiplex Diagnostic Market In 2022 & 2029
- Figure 13 North America Is Expected To Dominate The Europe Syndromic Multiplex Diagnostic Market And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Europe Syndromic Multiplex Diagnostic Market
- Figure 15 Total Cases Of Covid-19 In North America
- Figure 16 Total Cases Of Covid-19 In Europe
- Figure 17 National Health Expenditure Vs Medical Device Expenditure, U.S., 2019
- Figure 18 Europe Syndromic Multiplex Diagnostic Market: By Product & Services, 2021
- Figure 19 Europe Syndromic Multiplex Diagnostic Market: By Product & Services, 2022-2029 (Usd Million)
- Figure 20 Europe Syndromic Multiplex Diagnostic Market: By Product & Services, Cagr (2022-2029)
- Figure 21 Europe Syndromic Multiplex Diagnostic Market: By Product & Services, Lifeline Curve
- Figure 22 Europe Syndromic Multiplex Diagnostic Market: By Infection Type, 2021
- Figure 23 Europe Syndromic Multiplex Diagnostic Market: By Infection Type, 2022-2029 (Usd Million)
- Figure 24 Europe Syndromic Multiplex Diagnostic Market: By Infection Type, Cagr (2022-2029)
- Figure 25 Europe Syndromic Multiplex Diagnostic Market: By Infection Type, Lifeline Curve
- Figure 26 Europe Syndromic Multiplex Diagnostic Market: By Disease, 2021
- Figure 27 Europe Syndromic Multiplex Diagnostic Market: By Disease, 2022-2029 (Usd Million)
- Figure 28 Europe Syndromic Multiplex Diagnostic Market: By Disease, Cagr (2022-2029)
- Figure 29 Europe Syndromic Multiplex Diagnostic Market: By Disease, Lifeline Curve
- Figure 30 Europe Syndromic Multiplex Diagnostic Market: By Panels Type, 2021
- Figure 31 Europe Syndromic Multiplex Diagnostic Market: By Panels Type, 2022-2029 (Usd Million)
- Figure 32 Europe Syndromic Multiplex Diagnostic Market: By Panels Type, Cagr (2022-2029)
- Figure 33 Europe Syndromic Multiplex Diagnostic Market: By Panels Type, Lifeline Curve
- Figure 34 Europe Syndromic Multiplex Diagnostic Market: By End User, 2021
- Figure 35 Europe Syndromic Multiplex Diagnostic Market: By End User, 2022-2029 (Usd Million)
- Figure 36 Europe Syndromic Multiplex Diagnostic Market: By End User, Cagr (2022-2029)
- Figure 37 Europe Syndromic Multiplex Diagnostic Market: By End User, Lifeline Curve
- Figure 38 Europe Syndromic Multiplex Diagnostic Market: Snapshot (2021)
- Figure 39 Europe Syndromic Multiplex Diagnostic Market: By Country (2021)
- Figure 40 Europe Syndromic Multiplex Diagnostic Market: By Country (2022 & 2029)
- Figure 41 Europe Syndromic Multiplex Diagnostic Market: By Country (2021 & 2029)
- Figure 42 Europe Syndromic Multiplex Diagnostic Market: By Product And Services (2022-2029)
- Figure 43 Europe Syndromic Multiplex Diagnostic Market: Company Share 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook